GlucaGen (Boehringer Ingelheim Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the GlucaGen drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Antihypoglycemic Agent [EPC],Gastrointestinal Motility Inhibitor [EPC],Increased Gluconeogenesis [PE],Increased Glycogenolysis [PE],Decreased GI Smooth Muscle Tone [PE],Decreased GI Motility [PE],Decreased Glycolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | glucagon hydrochloride |
| SUBSTANCE NAME: | GLUCAGON HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antihypoglycemic Agent [EPC],Gastrointestinal Motility Inhibitor [EPC],Increased Gluconeogenesis [PE],Increased Glycogenolysis [PE],Decreased GI Smooth Muscle Tone [PE],Decreased GI Motility [PE],Decreased Glycolysis [PE] |
| ROUTE: | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2005-06-22 |
| END MARKETING DATE: | 0000-00-00 |
GlucaGen HUMAN PRESCRIPTION DRUG Details:
| Item Description | GlucaGen from Boehringer Ingelheim Pharmaceuticals, Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/mL) |
| START MARKETING DATE: | 2005-06-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0053_ddb60ccd-e41c-4a52-a84d-f164073f3fec |
| PRODUCT NDC: | 0597-0053 |
| APPLICATION NUMBER: | NDA020918 |
Other GLUCAGON HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
